![Lars Thomander](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lars Thomander
Corporate Officer/Principal chez University of Uppsala
Postes actifs de Lars Thomander
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Uppsala | Corporate Officer/Principal | - | - |
Historique de carrière de Lars Thomander
Anciens postes connus de Lars Thomander
Sociétés | Poste | Début | Fin |
---|---|---|---|
Abbott Scandinavia AB | Directeur Technique/Scientifique/R&D | 01/01/2009 | 01/01/2013 |
AbbVie AB
![]() AbbVie AB Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie AB is a clinical research and development pharmaceutical company. The company is based in Solna, Sweden. AbbVie was founded in 2013 and operates in the pharmaceutical industry, focusing on research and development. | Directeur Technique/Scientifique/R&D | 01/01/2009 | 01/01/2013 |
ELI LILLY AND COMPANY | Directeur Technique/Scientifique/R&D | - | - |
Foundation for Pharmaceutical Medicine | Directeur/Membre du Conseil | - | - |
Swedish Pharmaceutical Society | President | - | - |
Hlt Konsult AB | Directeur/Membre du Conseil | - | - |
Fondateur | - | - | |
CaptiGel AB
![]() CaptiGel AB BiotechnologyHealth Technology CaptiGel AB provides patented technological platform for encapsulation and controlled release of biomolecules and microorganisms. It offers a technology based on eco-friendly and commonly used raw materials, which will provide protective capabilities of the encapsulated material. The company was founded Vadim Kessler, Gulaim Seisenbaeva, Maria Unell, and Sebastian Håkansson in 2009 and is headquartered in Uppsala, Sweden. | Président | 01/01/2014 | - |
Double Bond Pharmaceutical International AB
![]() Double Bond Pharmaceutical International AB BiotechnologyHealth Technology Double Bond Pharmaceutical International AB is a pharmaceutical company, which engages in developing and commercializing approaches for treatment of cancers, infections, autoimmune diseases, and life-threatening disorders. It also involves in designing medicinal products for patients suffering from diseases such as cancer, inflammation, asthma or diabetes. The company was founded on November 21, 2014 and is headquartered in Uppsala, Sweden. | Directeur/Membre du Conseil | 01/04/2015 | - |
Statistiques
Internationale
Suède | 9 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Chairman | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
![]() | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Entreprise privées | 6 |
---|---|
CaptiGel AB
![]() CaptiGel AB BiotechnologyHealth Technology CaptiGel AB provides patented technological platform for encapsulation and controlled release of biomolecules and microorganisms. It offers a technology based on eco-friendly and commonly used raw materials, which will provide protective capabilities of the encapsulated material. The company was founded Vadim Kessler, Gulaim Seisenbaeva, Maria Unell, and Sebastian Håkansson in 2009 and is headquartered in Uppsala, Sweden. | Health Technology |
Hlt Konsult AB | |
Abbott Scandinavia AB | |
AbbVie AB
![]() AbbVie AB Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie AB is a clinical research and development pharmaceutical company. The company is based in Solna, Sweden. AbbVie was founded in 2013 and operates in the pharmaceutical industry, focusing on research and development. | Commercial Services |
Swedish Pharmaceutical Society | |
Foundation for Pharmaceutical Medicine |
- Bourse
- Insiders
- Lars Thomander
- Expérience